Annals of Surgical Oncology

, Volume 2, Issue 1, pp 71–76

Effect of glutamine on tumor and host growth

  • David L. Bartlett
  • Scott Charland
  • Michael H. Torosian
Original Articles

DOI: 10.1007/BF02303705

Cite this article as:
Bartlett, D.L., Charland, S. & Torosian, M.H. Annals of Surgical Oncology (1995) 2: 71. doi:10.1007/BF02303705


Background: Oral glutamine supplementation has been found to support gastrointestinal mucosal growth and increase intestinal and systemic toxicity after chemotherapy and radiation therapy. Glutamine is also an important nutrient for rapidly proliferating tumor cells. However, it is not clear whether long-term glutamine supplementation in the tumor-bearing host has a selective benefit for host growth or tumor cell proliferation.

Methods: To study the effect of glutamine in tumor-bearing animals, 30 Lewis/Wistar rats with subcutaneous mammary tumor implants (MAC-33) were randomized to receive a 3% glutamine- or 3% glycerine-enriched (control) diet for 25 days.

Results: No significant difference was found in carcass weight, primary tumor weight, or spontaneous pulmonary metastasis with glutamine supplementation. Tumor cell cycle kinetics (aneuploidy, %S and %S [synthetic] + G2/M [growth fraction]) were similar between glutamine-supplemented and control animals. A trophic effect of glutamine on distal ileal mucosa was seen with increased DNA content (344±68 vs. 184±38 µg/100 mg tissue) (p<0.05) and RNA content (435±44 VS. 335±30 µg/100 mg tissue) (p=0.06) compared with control animals. No detectable differences were observed in liver or muscle, or in tumor DNA, RNA, or protein content.

Conclusions: These findings confirm the trophic effect of glutamine on small intestinal mucosa and suggest that glutamine can be administered to the tumor-bearing host over a long period of time without significantly stimulating tumor growth kinetics or metastasis.

Key Words

Tumor Metastasis Glutamine Nutrition 

Copyright information

© The Society of Surgical Oncology, Inc. 1995

Authors and Affiliations

  • David L. Bartlett
    • 1
  • Scott Charland
    • 1
  • Michael H. Torosian
    • 1
  1. 1.From the Department of Surgery and Harrison Department of Surgical ResearchUniversity of Pennsylvania School of Medicine, and the Veterans Administration Medical CenterPhiladelphiaUSA
  2. 2.Division of Surgical OncologyHospital of the University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations